Abstract:The concept of heterogeneity among obese individuals in their risk for developing metabolic dysfunction and associated complications has been recognized for decades. At the origin of the heterogeneity idea is the acknowledgement that individuals with central obesity are more prone to developing type 2 diabetes and cardiovascular disease than those with peripheral obesity. There have been attempts to categorize subjects according to their metabolic health and degree of obesity giving rise to different obese and non-obese phenotypes that include metabolically unhealthy normal-weight (MUHNW), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Individuals belonging to the MHO phenotype are obese according to their body mass index although exhibiting fewer or none metabolic anomalies such as type 2 diabetes, dyslipidemia, hypertension, and/or unfavorable inflammatory and fribinolytic profiles. However, some authors claim that MHO is only transient in nature. Additionally, the phenotype categorization is controversial as it lacks standardized definitions possibly blurring the distinction between obesity phenotypes and confounding the associations with health outcomes. To add to the discussion, the factors underlying the origin or protection from metabolic deterioration and cardiometabolic risk for these subclasses are being intensely investigated and several hypotheses have been put forward. In the present review, we compare the different definitions of obesity phenotypes and present several possible factors underlying them (adipose tissue distribution and cellularity, contaminant accumulation on the adipose tissue, dysbiosis and metabolic endotoxemia imposing on to the endocannabinoid tone and inflammasome, and nutrient intake and dietary patterns) having inflammatory activation at the center.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the heterogeneity of metabolic dysfunction and the risk of related complications in obese populations. Specifically, the paper explores the criteria for distinguishing between metabolically healthy and unhealthy obese individuals and their impact on health outcomes. Different definitions of obesity phenotypes are discussed in the paper, especially phenotypes such as metabolically healthy obesity (MHO), metabolically unhealthy normal - weight (MUHNW), and metabolically unhealthy obesity (MUO), and the differences between these phenotypes and their underlying biological mechanisms are analyzed. ### Main problem points: 1. **Metabolic heterogeneity in obese populations**: - The paper points out that obese individuals have significant differences in the risk of developing metabolic dysfunction and related complications. This understanding of heterogeneity stems from the fact that centrally obese individuals are more likely to develop type 2 diabetes and cardiovascular diseases than peripherally obese individuals. 2. **Definitions of different obesity phenotypes**: - The paper compares in detail the definitions of MHO, MUHNW, and MUO in different studies, emphasizing the inconsistency and lack of standardization of these definitions. This inconsistency may lead to confusion about obesity phenotypes, which in turn affects the study of health outcomes. 3. **Underlying biological mechanisms**: - The paper explores the potential factors leading to metabolically healthy or unhealthy obesity, including adipose tissue distribution and cell characteristics, pollutant accumulation, gut microbiota dysbiosis, the impact of metabolic endotoxemia on the endocannabinoid system and inflammasomes, as well as nutrient intake and dietary patterns. ### Specific problems: - **Metabolically healthy obesity (MHO)**: The paper discusses the definition of MHO and its variability in different studies. Although individuals with MHO have a BMI exceeding 30 kg/m², they usually do not have metabolic abnormalities such as type 2 diabetes, dyslipidemia, and hypertension. However, whether MHO is a long - term stable phenotype remains controversial. - **Metabolically unhealthy normal - weight (MUHNW)**: The paper describes that individuals with MUHNW have normal BMIs but have metabolic abnormalities, such as insulin resistance, hypertension, and high triglyceride levels. - **Metabolically unhealthy obesity (MUO)**: Individuals with MUO not only have a BMI exceeding 30 kg/m² but also have multiple metabolic abnormalities and are considered a high - risk group for cardiovascular diseases and type 2 diabetes. Through these discussions, the paper aims to provide a clearer framework for the definition and classification of obesity and metabolic health phenotypes to promote the development of more effective prevention and treatment strategies.

Metabolically Healthy Obesity—Heterogeneity in Definitions and Unconventional Factors

Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight

Metabolically healthy obesity: Misleading phrase or healthy phenotype?

Metabolically healthy and unhealthy obesity: contemporary views on the main differences. Review

Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity

The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function

Is the Metabolically Healthy Obesity Phenotype an Irrelevant Artifact for Public Health?

Obesity, metabolic health and omics: Current status and future directions

Metabolically healthy obesity across the life course: epidemiology, determinants, and implications

Distinguishing health-related parameters between metabolically healthy and metabolically unhealthy obesity in women

Profile of Individuals Who Are Metabolically Healthy Obese Using Different Definition Criteria. A Population-Based Analysis in the Spanish Population

Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals

Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review

The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes

Comparing an adiposopathy approach with four popular classifications schemes to categorize the metabolic profile of postmenopausal women

1236-P: Cardiometabolic Disease Risk in Metabolically Unhealthy vs. Healthy in Normal Weight and Obesity: Results from 2015 and 20KNHNES Data

Metabolic phenotyping in people living with obesity: Implications for dietary prevention

A comprehensive metabolic profiling of the metabolically healthy obesity phenotype

The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used

Associations of Metabolic Heterogeneity of Obesity with Frailty Progression: Results from Two Prospective Cohorts

Insulin resistance persists despite a metabolically healthy obesity phenotype